vs
ASP Isotopes Inc.（ASPI）与卡博特（CBT）财务数据对比。点击上方公司名可切换其他公司
卡博特的季度营收约是ASP Isotopes Inc.的51.0倍（$849.0M vs $16.7M）。ASP Isotopes Inc.同比增速更快（1295.7% vs -11.1%）。卡博特自由现金流更多（$57.0M vs $-47.4M）。过去两年ASP Isotopes Inc.的营收复合增速更高（345.2% vs -8.7%）
ASP Isotopes Inc.是一家特种材料企业，专注于高纯度定制同位素的研发与生产，产品广泛应用于核医学、靶向抗癌治疗、清洁能源及工业研究等领域，客户覆盖北美、欧洲及亚太地区。
卡博特公司是总部位于美国马萨诸塞州波士顿的特种化学品和高性能材料企业，业务覆盖全球20多个国家，拥有36座生产工厂、8个研发中心及28个销售办事处，在特种材料领域具备全球领先的技术和服务能力。
ASPI vs CBT — 直观对比
营收规模更大
CBT
是对方的51.0倍
$16.7M
营收增速更快
ASPI
高出1306.8%
-11.1%
自由现金流更多
CBT
多$104.4M
$-47.4M
两年增速更快
ASPI
近两年复合增速
-8.7%
损益表 — Q4 2025 vs Q1 2026
| 指标 | | |
|---|---|---|
| 营收 | $16.7M | $849.0M |
| 净利润 | — | $73.0M |
| 毛利率 | 12.5% | 24.9% |
| 营业利润率 | — | 15.2% |
| 净利率 | — | 8.6% |
| 营收同比 | 1295.7% | -11.1% |
| 净利润同比 | -586.8% | -21.5% |
| 每股收益（稀释后） | — | $1.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASPICBT
| Q4 25 | $16.7M | $849.0M | ||
| Q3 25 | $4.9M | $899.0M | ||
| Q2 25 | $1.2M | $923.0M | ||
| Q1 25 | $1.1M | $936.0M | ||
| Q4 24 | $1.2M | $955.0M | ||
| Q3 24 | $1.1M | $1.0B | ||
| Q2 24 | $1.0M | $1.0B | ||
| Q1 24 | $840.4K | $1.0B |
净利润ASPICBT
| Q4 25 | — | $73.0M | ||
| Q3 25 | $-12.9M | $43.0M | ||
| Q2 25 | $-75.2M | $101.0M | ||
| Q1 25 | $-8.5M | $94.0M | ||
| Q4 24 | — | $93.0M | ||
| Q3 24 | $-7.4M | $137.0M | ||
| Q2 24 | $-8.9M | $109.0M | ||
| Q1 24 | $-7.0M | $84.0M |
毛利率ASPICBT
| Q4 25 | 12.5% | 24.9% | ||
| Q3 25 | 8.7% | 24.5% | ||
| Q2 25 | 47.7% | 26.4% | ||
| Q1 25 | 29.7% | 25.7% | ||
| Q4 24 | 50.7% | 24.6% | ||
| Q3 24 | 27.0% | 24.0% | ||
| Q2 24 | 41.2% | 25.2% | ||
| Q1 24 | 33.2% | 24.1% |
营业利润率ASPICBT
| Q4 25 | — | 15.2% | ||
| Q3 25 | -306.1% | 15.2% | ||
| Q2 25 | -998.8% | 18.1% | ||
| Q1 25 | -721.9% | 17.3% | ||
| Q4 24 | — | 16.2% | ||
| Q3 24 | -499.6% | 15.0% | ||
| Q2 24 | -729.5% | 16.9% | ||
| Q1 24 | -691.9% | 15.3% |
净利率ASPICBT
| Q4 25 | — | 8.6% | ||
| Q3 25 | -263.7% | 4.8% | ||
| Q2 25 | -6271.7% | 10.9% | ||
| Q1 25 | -768.1% | 10.0% | ||
| Q4 24 | — | 9.7% | ||
| Q3 24 | -676.2% | 13.7% | ||
| Q2 24 | -868.8% | 10.7% | ||
| Q1 24 | -828.8% | 8.2% |
每股收益（稀释后）ASPICBT
| Q4 25 | — | $1.37 | ||
| Q3 25 | $-0.15 | $0.80 | ||
| Q2 25 | $-1.03 | $1.86 | ||
| Q1 25 | $-0.12 | $1.69 | ||
| Q4 24 | — | $1.67 | ||
| Q3 24 | $-0.12 | $2.41 | ||
| Q2 24 | $-0.24 | $1.94 | ||
| Q1 24 | $-0.16 | $1.49 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $333.3M | $230.0M |
| 总债务越低越好 | $14.4M | — |
| 股东权益账面价值 | $204.2M | $1.6B |
| 总资产 | $498.0M | $3.8B |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势，按日历期对齐
现金及短期投资ASPICBT
| Q4 25 | $333.3M | $230.0M | ||
| Q3 25 | $113.9M | $258.0M | ||
| Q2 25 | $67.7M | $239.0M | ||
| Q1 25 | $56.0M | $213.0M | ||
| Q4 24 | $61.9M | $183.0M | ||
| Q3 24 | $51.6M | $223.0M | ||
| Q2 24 | — | $197.0M | ||
| Q1 24 | — | $206.0M |
总债务ASPICBT
| Q4 25 | $14.4M | — | ||
| Q3 25 | $13.9M | $1.1B | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $2.4M | — | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ASPICBT
| Q4 25 | $204.2M | $1.6B | ||
| Q3 25 | $74.1M | $1.6B | ||
| Q2 25 | $25.2M | $1.5B | ||
| Q1 25 | $42.5M | $1.4B | ||
| Q4 24 | $47.9M | $1.4B | ||
| Q3 24 | $38.7M | $1.4B | ||
| Q2 24 | $11.0M | $1.3B | ||
| Q1 24 | $10.5M | $1.4B |
总资产ASPICBT
| Q4 25 | $498.0M | $3.8B | ||
| Q3 25 | $225.9M | $3.8B | ||
| Q2 25 | $135.9M | $3.8B | ||
| Q1 25 | $90.9M | $3.8B | ||
| Q4 24 | $94.3M | $3.6B | ||
| Q3 24 | $84.1M | $3.7B | ||
| Q2 24 | $54.8M | $3.6B | ||
| Q1 24 | $45.4M | $3.6B |
负债/权益比ASPICBT
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.19× | 0.70× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | — | 0.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.8M | $126.0M |
| 自由现金流经营现金流 - 资本支出 | $-47.4M | $57.0M |
| 自由现金流率自由现金流/营收 | -284.7% | 6.7% |
| 资本支出强度资本支出/营收 | 57.9% | 8.1% |
| 现金转化率经营现金流/净利润 | — | 1.73× |
| 过去12个月自由现金流最近4个季度 | $-74.6M | $401.0M |
8季度趋势，按日历期对齐
经营现金流ASPICBT
| Q4 25 | $-37.8M | $126.0M | ||
| Q3 25 | $-8.9M | $219.0M | ||
| Q2 25 | $-7.9M | $249.0M | ||
| Q1 25 | $-3.2M | $73.0M | ||
| Q4 24 | $-16.7M | $124.0M | ||
| Q3 24 | $-4.8M | $204.0M | ||
| Q2 24 | $-5.1M | $207.0M | ||
| Q1 24 | $-3.0M | $176.0M |
自由现金流ASPICBT
| Q4 25 | $-47.4M | $57.0M | ||
| Q3 25 | $-12.0M | $155.0M | ||
| Q2 25 | $-9.7M | $188.0M | ||
| Q1 25 | $-5.5M | $1.0M | ||
| Q4 24 | $-26.4M | $47.0M | ||
| Q3 24 | $-9.3M | $112.0M | ||
| Q2 24 | $-7.7M | $155.0M | ||
| Q1 24 | $-4.2M | $133.0M |
自由现金流率ASPICBT
| Q4 25 | -284.7% | 6.7% | ||
| Q3 25 | -245.5% | 17.2% | ||
| Q2 25 | -809.4% | 20.4% | ||
| Q1 25 | -497.4% | 0.1% | ||
| Q4 24 | -2209.3% | 4.9% | ||
| Q3 24 | -857.3% | 11.2% | ||
| Q2 24 | -757.8% | 15.3% | ||
| Q1 24 | -501.7% | 13.1% |
资本支出强度ASPICBT
| Q4 25 | 57.9% | 8.1% | ||
| Q3 25 | 64.4% | 7.1% | ||
| Q2 25 | 150.1% | 6.6% | ||
| Q1 25 | 209.6% | 7.7% | ||
| Q4 24 | 810.5% | 8.1% | ||
| Q3 24 | 412.3% | 9.2% | ||
| Q2 24 | 256.5% | 5.1% | ||
| Q1 24 | 148.3% | 4.2% |
现金转化率ASPICBT
| Q4 25 | — | 1.73× | ||
| Q3 25 | — | 5.09× | ||
| Q2 25 | — | 2.47× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 1.33× | ||
| Q3 24 | — | 1.49× | ||
| Q2 24 | — | 1.90× | ||
| Q1 24 | — | 2.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASPI
暂无分部数据
CBT
| Reinforcement Materials | $520.0M | 61% |
| Performance Chemicals | $300.0M | 35% |
| Shipping And Handling | $25.0M | 3% |
| Other Products And Services | $4.0M | 0% |
